Insulet (PODD)
(Delayed Data from NSDQ)
$172.27 USD
+11.25 (6.99%)
Updated May 14, 2024 04:00 PM ET
After-Market: $172.26 -0.01 (-0.01%) 7:18 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Brokerage Reports
Insulet Corporation [PODD]
Reports for Purchase
Showing records 301 - 320 ( 341 total )
Company: Insulet Corporation
Industry: Medical - Products
Q4 REVENUES ON-TRACK-LOSS SLIGHTLY HIGHER BUT OF LITTLE CONCERN-BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Bucking Headwinds - Three Medical Device Companies To Ride Into The New Year
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Strong Q3 Rev Growth Negatively Affected By Production Problem - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Manufacturing Issues highlighted in Q3 shortfall All eyes on next-gen OmniPod clearance
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Respectable Q3 despite disruption, maintaining BUY but reducing PT to $18.60
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Manufacturing Issues highlighted in Q3 shortfall All eyes on next-gen OmniPod clearance
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
The Truffle Shuffle-Diabetes Edition: Investment Implications of Obesity on Diabetes Devices
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q2-11; Banking on the next-gen OmniPod; Upgrading to Market Perform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q2-11; Banking on the next-gen OmniPod; Upgrading to Market Perform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Difficult as it is, we are downgrading the stock to an UnderPerform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Difficult as it is, we are downgrading the stock to an UnderPerform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S